
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.450 | 1.070 | 0.620 |
Shares | 99.550 | 99.550 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.037 | 16.655 |
Price to Book | 2.688 | 3.875 |
Price to Sales | 2.006 | 5.245 |
Price to Cash Flow | 12.412 | 14.044 |
Dividend Yield | 1.337 | 0.520 |
5 Years Earnings Growth | 4.809 | 6.558 |
Number of long holdings: 95
Number of short holdings: 21
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.59 | 450.04 | +0.68% | |
Novartis | CH0012005267 | 3.37 | 102.88 | +1.66% | |
Gilead | US3755581036 | 3.24 | 112.61 | -0.09% | |
PTC Therapeutics | US69366J2006 | 3.21 | 54.63 | +4.20% | |
Astellas Pharma Inc. | JP3942400007 | 3.06 | 1,664.0 | +0.30% | |
Amgen | US0311621009 | 3.05 | 282.81 | -1.43% | |
Ionis Pharma | US4622221004 | 2.94 | 60.33 | +4.93% | |
Lonza Group | CH0013841017 | 2.72 | 569.40 | +1.03% | |
Bristol-Myers Squibb | US1101221083 | 2.72 | 47.42 | +0.02% | |
Biomarin Pharma | US09061G1013 | 2.70 | 58.63 | -0.78% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C dist USD h | 16.83B | 4.64 | 8.17 | 4.83 | ||
JPI Global Income Fund C mth USD he | 16.83B | 4.64 | 8.18 | 4.84 | ||
JPI Global Income Fund D mth USD he | 16.83B | 4.10 | 7.05 | 3.76 | ||
Global Income Fund C div USD hedged | 16.83B | 4.64 | 8.18 | 4.84 | ||
JPI Global Income Fund A acc USD he | 16.83B | 5.82 | 6.38 | 4.16 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review